Amyloid-β protein aggregation-regulating factors

Details Amyloid-β protein aggregation-regulating factors Amyloid-β protein aggregation-regulating factors

2006-04-18

2006-04-18

Wax, Robert A. (Department: 1653)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C514S012200, C530S350000, C530S387100

Reexamination Certificate

active

07029860

ABSTRACT:
The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-β protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-β protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-β protein.

REFERENCES:
patent: 979870 (2000-02-01), None
patent: 1067182 (2001-01-01), None
patent: 1067182 (2001-01-01), None
patent: 1067182 (2001-01-01), None
patent: 98/21328 (1998-05-01), None
patent: 99/55865 (1999-11-01), None
J. Rankin, et al., “Partial cloning and assignment1of WNTΛ to human chromosome bank 2q35 by in situ hybridization”, Cytogenet Cell Genet. vol. 84(1-2), 1999, p. 50-52.
GENBANK Accession No. AF079522, Jul. 1, 1999.
B. H. Anderton, “Alzheimer's disease: Clues from flies and worms”, Current Biology, vol. 9(3), 1999, p. R106-R109.
A. Caricasole, et al., “The Wnt pathway, cell-cycle activation and β-amyloid: novel therapeutic strategies in Alzheimer's disease?”, Trends in Pharmacological Sciences, vol. 24(5), 2003, p. 233-238.
B.J. Gavin et al., “Expression of multiple novel Wnt-1/Int-1-related genes during fetal and adult mouse developments” Genes & Development, vol. 4, No. 12B, pp. 2319-2332, 1990.
J. Ghanta et al., “A strategy for designing inhibitors of beta-amyloid toxicity”, Journal of Biological Chemistry, vol. 271, No. 47, pp. 29525-29528, 1996.
Y. Du et al., “alpha2-Macroglobulin attenuates beta-amyloid peptid 1-40 fibril formation and associated neurotoxicity of cultured fetal rat”, Journal of Neurochemistry, vol. 70, No. 3, pp. 1182-1188, 1998.
M.M. Pallito et al., “Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity”, Biochemistry, vol. 38, No. 12, pp. 3570-3578, Mar. 1999.
H. Levine III, et al., “Quantification of -sheet amyloid fibril structures with thioflavin T”, Methods in Enzymology, vol. 309, pp. 274-284, Oct. 1999.
Inestrosa, et al., “Acetyicholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme,” Neuron. Apr. 1996, vol. 16, No. 4, pp. 881-891.
Drouet, et al., “Laminin 1 attenuates beta-amyloid peptide Abeta (1-40) neurotoxicity of cultured fetal rat cortical neurons.” Journal of Neurochemistry. Aug. 1999, vol. 73, No. 2, pp. 742-749.

Affiliated with

Also associated with

Rating

Amyloid-β protein aggregation-regulating factors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amyloid-β protein aggregation-regulating factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amyloid-β protein aggregation-regulating factors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3612329